1. Home
  2. STEL vs TRVI Comparison

STEL vs TRVI Comparison

Compare STEL & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stellar Bancorp Inc.

STEL

Stellar Bancorp Inc.

HOLD

Current Price

$37.61

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$13.24

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STEL
TRVI
Founded
2007
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
STEL
TRVI
Price
$37.61
$13.24
Analyst Decision
Buy
Strong Buy
Analyst Count
2
12
Target Price
$37.00
$20.38
AVG Volume (30 Days)
666.2K
1.2M
Earning Date
04-29-2026
01-01-0001
Dividend Yield
1.60%
N/A
EPS Growth
N/A
N/A
EPS
1.99
N/A
Revenue
$6,282,000.00
N/A
Revenue This Year
$10.14
N/A
Revenue Next Year
$4.65
N/A
P/E Ratio
$18.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.13
$4.24
52 Week High
$40.21
$14.39

Technical Indicators

Market Signals
Indicator
STEL
TRVI
Relative Strength Index (RSI) 52.36 67.91
Support Level $28.92 $10.04
Resistance Level $40.21 $14.39
Average True Range (ATR) 0.77 0.69
MACD -0.37 0.25
Stochastic Oscillator 17.83 84.82

Price Performance

Historical Comparison
STEL
TRVI

About STEL Stellar Bancorp Inc.

Stellar Bancorp Inc is a U.S. based bank holding company. Through its subsidiary, Stellar Bank, the company provides a diversified range of commercial banking services predominantly to small to medium sized businesses, professionals, and individual customers. Its offerings include different types of loans, such as mortgage loans, home equity loans, automobile loans, etc.; deposit products, such as checking accounts, commercial accounts, money market accounts, savings accounts, etc.; and other banking services like mobile banking, debit cards, cash management and wire transfer services, letters of credit, and others.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: